Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D05ZJG
|
||||
| Former ID |
DNAP001612
|
||||
| Drug Name |
Anisodine
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Central and peripheral nervous diseases [ICD10:G96.9] | Approved | [551871] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C17H21NO5
|
||||
| Canonical SMILES |
CN1C2CC(CC1C3C2O3)OC(=O)C(CO)(C4=CC=CC=C4)O
|
||||
| InChI |
1S/C17H21NO5/c1-18-12-7-11(8-13(18)15-14(12)23-15)22-16(20)17(21,9-19)10-5-3-2-4-6-10/h2-6,11-15,19,21H,7-9H2,1H3
|
||||
| InChIKey |
JEJREKXHLFEVHN-UHFFFAOYSA-N
|
||||
| CAS Number |
CAS 52646-92-1
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | Beta-1 adrenergic receptor | Target Info | Modulator | [533488] | |
| Muscarinic acetylcholine receptor M5 | Target Info | Modulator | [533488] | ||
| KEGG Pathway | Calcium signaling pathway | ||||
| cGMP-PKG signaling pathway | |||||
| cAMP signaling pathway | |||||
| Neuroactive ligand-receptor interaction | |||||
| Endocytosis | |||||
| Adrenergic signaling in cardiomyocytes | |||||
| Gap junction | |||||
| Salivary secretion | |||||
| Dilated cardiomyopathyhsa04020:Calcium signaling pathway | |||||
| Cholinergic synapse | |||||
| Regulation of actin cytoskeleton | |||||
| PathWhiz Pathway | Muscle/Heart Contraction | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.